Abstract
Ischemic heart diseases, in particular, acute myocardial infarction (AMI), represent one of the major causes of death, both national and worldwide, and have the potential of damaging the health of those who survive such events. Existing treatments, such as angioplasty and the use of thrombolytics, are not sufficient to mitigate the situation and present risks and disadvantages. Thus, as a…